Related Experiment Video
Updated: Jan 22, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Modeling Hypertrophic Cardiomyopathy: Mechanistic Insights and Pharmacological Intervention
Diogo Mosqueira1, James G W Smith2, Jamie R Bhagwan1
1Department of Stem Cell Biology, Centre of Biomolecular Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
Insights
Hypertrophic cardiomyopathy (HCM) research utilizes various models to understand cardiac dysfunction. Human pluripotent stem cell (hPSC) models offer new insights into HCM mechanisms and therapeutic development.
Area of Science:
- Cardiovascular Research
- Genetics and Molecular Biology
- Stem Cell Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is a common genetic heart disease characterized by cardiac dysfunction.
- Mutations in sarcomeric genes are frequently associated with HCM pathogenesis.
- Existing models like tissue explants and isolated cells have revealed disease hallmarks but have limitations.
Purpose of the Study:
- To compare recent advancements in understanding HCM mechanisms across different experimental models.
- To highlight consistencies and discrepancies in findings from various HCM models.
- To explore how model-based insights inform the development of novel HCM therapeutics.
Main Methods:
- Review and comparison of data from diverse HCM models, including traditional systems and human pluripotent stem cell (hPSC)-based models.
- Analysis of studies investigating sarcomeric gene mutations and their impact on cardiac function.
- Evaluation of therapeutic strategies targeting metabolism, contraction, and rhythm in HCM.
Main Results:
- Various models have identified key features of hypertrophic cardiomyopathy (HCM).
- Human pluripotent stem cell (hPSC) models provide complementary data and challenge previous findings.
- Similarities and differences in HCM mechanisms are observed across different modeling systems.
Conclusions:
- Different experimental models offer valuable, sometimes contrasting, insights into hypertrophic cardiomyopathy (HCM) pathogenesis.
- Human pluripotent stem cell (hPSC) models are emerging as powerful tools for HCM research.
- Understanding HCM mechanisms through diverse models is crucial for designing effective therapeutic interventions.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a prevalent and complex cardiovascular disease where cardiac dysfunction often associates with mutations in sarcomeric genes. Various models based on tissue explants, isolated cardiomyocytes, skinned myofibrils, and purified actin/myosin preparations have uncovered disease hallmarks, enabling the development of putative therapeutics, with some reaching clinical trials. Newly developed human pluripotent stem cell (hPSC)-based models could be complementary by overcoming some of the inconsistencies of earlier systems, whilst challenging and/or clarifying previous findings. In this article we compare recent progress in unveiling multiple HCM mechanisms in different models, highlighting similarities and discrepancies. We explore how insight is facilitating the design of new HCM therapeutics, including those that regulate metabolism, contraction and heart rhythm, providing a future perspective for treatment of HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mechanistic Models: Overview of Compartment Models
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mechanistic Models: Compartment Models in Individual and Population Analysis
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...

